Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Overjet Partners with Affinity Dental Management to Improve Lives through AI
Overjet announced today it has partnered with Affinity Dental Management to provide its practices with […]
ABL Partners With KaliVir Immunotherapeutics to Advance Development of Oncolytic Viruses
ABL, a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and […]
Tampa General Hospital Offers New Treatment Option for Recurrent Brain Cancer to Improve Quality of Life
Tampa General Hospital and USF Health Morsani College of Medicine physicians are the first in Hillsborough County to bring patients […]
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Now Available in the Philippines
A NEW drug shown to significantly reduce the risk of cancer recurrence or death in […]
EarlySign Announces Strategic Collaboration Agreement with Roche on AI Solution for Early Detection of Lung Cancer
Medial EarlySign (earlysign.com), a pioneering company developing Artificial Intelligence (AI) based clinical predictive analytics, announced today […]
Remidio's Medios AI Shows Significant Promise in Last-mile Screening for Referable Glaucoma
Glaucoma, one of the world’s leading causes of irreversible blindness, is expected to affect an […]
FUJIFILM Healthcare Europe Launches a Dedicated Prostate Fusion Imaging Platform
FUJIFILM Healthcare Europe is pleased to have unveiled the ARIETTA™ 65 IntuitiveFusion, a diagnostic ultrasound […]
Smart CRP Test Gets Green Light for Professional Use as Swiss Medtech Company Expands Across Europe
Swiss medtech company Bloom Diagnostics has today announced the launch of the Bloom Inflammation Test, […]
Unilabs Sweden Launches Subtle Medical's AI-powered Imaging Technology to Further Bolstering Patient Care
Unilabs, the leading diagnostic services provider, announced a partnership with Subtle Medical, a healthcare technology […]
Azra AI Expands Innovative Incidental Findings Technology to Help Clinicians Identify More Cancers
Azra AI‘s proprietary software — which uses artificial intelligence (AI) and natural language processing to […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more